How we connected at Melanoma March Virtual 2020
21 April 2020
We could not have asked for a better start to Melanoma March 2020 with superb events in Rockhampton and Sunshine Coast on Sunday 1 March. The following weekend a beautiful twilight gathering was held in Devonport on Saturday evening and then on Sunday inspiring events took place on the Central Coast and in Western Sydney, where participants demonstrated yet again that a bit of rain would not dampen the community spirit of Melanoma March.
After such a wonderful start it was then so disappointing when we made the decision to cancel our remaining 19 physical events, due to the escalating impact of COVID-19. We know what Melanoma March means to our community, so instead we created Melanoma March Virtual so that everyone across Australia could still come together (even if in a different way), as we have done at Melanoma March events for the last 9 years. We wanted people to still be able to honour loved ones and support each other.
It was so heart-warming to see how everyone embraced Melanoma March Virtual with enthusiasm. The creative ways in which people took steps whilst still social distancing was inspiring! Activities included bushwalking, bike-riding, backyard soccer, dog-walking, dancing, gardening, scooter-riding, stepping, horse-riding and even a morning tea party! Thank you so much to everyone who shared their pictures, videos and stories, and thank you to everyone who supported by donating over $310,000 to melanoma research. We hope, like us, everyone could feel the connection and support.
Watch the Event Welcome video below and see more of the activities on our Melanoma March Facebook or Instagram page.
Melanoma March 2020 Principal Partner is Ricky, Australia’s leading supplier of technical textiles and sun control fabrics.
It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.
A new study from The University of Sydney shows that sunscreen reduces melanoma risk by 40 per cent when used from a young age.
Melanoma Institute Australia (MIA) has launched a free e-learning portal to educate healthcare professionals about the latest advances in melanoma diagnosis and treatment.
When David lost his life last year, he was 33, with three daughters under six.
Clinical trials are just that – trials in a clinical setting to evaluate the effectiveness or otherwise of individual and combination treatments.
Melanoma Institute Australia scooped the award pool at the Annual Scientific Meeting of the International Academy of Pathology.
Melanoma patients across Australia will benefit from the release of updated clinical care guidelines.
An American study has discovered a link between early detection and marital status in melanoma diagnosis.
An international course on melanoma pathology in Paris, France co-directed by Professor Richard Scolyer took place over the weekend.
Professor Richard Scolyer highlights the difficulties of diagnosis following the Australian Story feature program on Emma Betts.
Cancer Australia releases 'stage at diagnosis' data for top five incidence cancers – including melanoma
For the first time in Australia, national data has been released on cancer stage at diagnosis. This data explores the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.
'Dear Emma' - a tribute to the life and times of a young woman determined to raise awareness about melanoma.
Carole Renouf, CEO for MIA thanks Toyota for helping fuel ongoing melanoma research.
Fraser Dykes tackled the Kokoda Trail on an eight day trek in memory of his friend Mark 'Bod' Boddison.
Harvard’s Clinical Professor Martin Mihm and MIA’s Conjoint Medical Director Professor Richard Scoyler delivered a series of lectures on melanoma pathology in Vancouver, British Colombia this week at the world’s biggest annual pathology meeting.
A round of applause for a well deserved win.
A message from our CEO, Carole Renouf
Piction, Brisbane, Bahturst and Port Macquarie march to end melanoma.
Australian researchers have greater clarity on the best course of treatment for patients with advanced melanoma which has spread to the brain.